The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities: | | | | | | | | | | | | | | | | | Six months ended June 30, | | | 2026 | | 2025 | | Cash paid for: | | (In millions) | | Interest | | $ | 115 | | | $ | 113 | | | Income taxes | | 116 | | | 155 | | | Deferred sales inducements | | 164 | | | 158 | | | Non-cash investing and financing activities: | | | | | | | | | | | Investments transferred subject to reinsurance agreement | | — | | | (500) | | | Exchange of note receivable for incremental share in consolidated subsidiary | | 36 | | | — | | | Investment received as non-cash consideration for sale of F&G Life Re | | 38 | | | — | | | Acquisitions | | | | 73 | | | Change in proceeds of sales of investments available for sale receivable in period | | (68) | | | 33 | | | Change in purchases of investments available for sale payable in period | | 116 | | | 206 | | | | | | | | Lease liabilities recognized in exchange for lease right-of-use assets | | 19 | | | 22 | | | Remeasurement of lease liabilities | | 37 | | | 32 | | | Liabilities assumed in connection with acquisitions | | | | | | Fair value of assets acquired | | 2 | | | 5 | | | Less: Total Purchase price | | 2 | | | 3 | | | Liabilities and noncontrolling interests assumed | | $ | — | | | $ | 2 | | | | | | | | | | | | | | | | | | | | | |
|